Used in the development of therapies targeting allergic and inflammatory diseases, particularly asthma, allergic rhinitis, and atopic dermatitis. This antibody blocks the CRTH2 receptor, which plays a key role in the activation and recruitment of immune cells like eosinophils and Th2 lymphocytes involved in allergic responses. By inhibiting this pathway, it helps reduce inflammation and allergic symptoms. It serves as a reference in research and drug development for evaluating the efficacy of new anti-CRTH2 agents and supports the design of biologics and small molecules for immune modulation.